Transcript Highlights:

• what's being done currently with active agents in what are colloquially called magic mushrooms, but psilocybin
• actually gone with the semi-synthetic route of creating a process that's biological to extract that psilocybin

Bills: HB 44, HB 2200, HB 1612, HB 2747, HB 2038, HB 3717, HB 1431, HB 3800, HB 3801, HB 3560, HB 3246

Keywords: HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care

Summary: The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.

Transcript Highlights:

• I know there's a psilocybin bill working its way through the Congress.

Transcript Highlights:

• But now you have also psilocybin and you have THC drinks, which are not traditionally defined by the

Summary: The committee met to hear an overview of Florida’s alcoholic beverage regulatory structure and a panel discussion on the state’s three-tier system. Emily Oglesby of DBPR explained the department’s licensing and enforcement roles, described common license types, and outlined the three tiers—manufacturers, distributors, and retailers—along with tied-house restrictions and several statutory exceptions for certified Florida farm wineries, breweries with tap rooms, brew pubs, and craft distilleries. Members asked about licensing fees, the number and classification of distributors and craft producers, and how the exceptions fit within the broader system. Panelists from craft breweries, craft distilleries, wholesalers, and retailers then discussed how the system affects market access, pricing, and product selection. Craft producers argued that Florida’s rules make it difficult for small brands to reach retailers because they must rely on distributors that often prioritize larger, higher-volume products; they said limited self-distribution or other reforms could help small businesses grow without eliminating wholesalers. Wholesalers and retailers defended the three-tier model as a public-safety and anti-monopoly framework, emphasizing investment in warehousing, sales, compliance, and product vetting, while noting that they already carry some craft products and make selections based on demand, quality, and shelf space. Members also explored related issues such as direct-to-consumer sales, the role of excise-tax audits and inspections, and the emerging market for hemp-derived THC beverages and other alternative drinks. DBPR and industry witnesses said alcohol and hemp products are regulated differently, and several speakers urged the Legislature to consider clearer rules for these products. The meeting ended with no bill vote or formal action; the chair thanked the panel and adjourned after Representative Yeager moved to rise, with no objection.

Transcript Highlights:

• I believe we've already passed the psilocybin thing in here before.
• turns it from a felony into a misdemeanor for possession of three-quarters of an ounce or less of psilocybin
• I believe we've already passed the psilocybin thing in here before.
• turns it from a felony into a misdemeanor for possession of three-quarters of an ounce or less of psilocybin

Keywords: 1189, house, all

Transcript Highlights:

• administration took a bold and necessary step by granting breakthrough therapy status to MDMA and psilocybin
• Emerging VA studies involving MDMA and psilocybin show remarkable potential, not just for improvement
• Emerging VA studies involving MDMA and Emerging VA studies involving MDMA and psilocybin<03:29:25.840
• > show<03:29:26.319> remarkable<03:29:27.040> potential, psilocybin show remarkable
• potential, psilocybin show remarkable potential, not<03:29:28.319> just<03:29:28.479> for<

Keywords: U.S. House of Representatives Floor Proceedings on Wednesday, June 25, 2025, 1012, house, all

Transcript Highlights:

• So, in terms of promising, we passed the psilocybin bill this year, and part of what we included with

Transcript Highlights:

• These include psychedelics such as MDMA, psilocybin, and ibogaine.

Keywords: veteran services, Secretary Collins, healthcare provisions, contract cancellations, transparency, accountability, committee meeting, legislation

Summary: During this committee meeting, various bills were discussed with a specific focus on veteran services and healthcare provisions. Notably, the cancellation of critical contracts under Secretary Collins sparked significant debate, with representatives emphasizing the adverse impact on veteran care. The meeting featured testimonies from veterans and stakeholders who expressed their concerns regarding the potential fallout of these cancellations, demonstrating the urgency of transparency and accountability in management decisions. Discussions also delved into various legislative proposals aimed at improving services for veterans amidst these challenges.

Transcript Highlights:

• . >> So some of the other substances that are Schedule I are things like heroin, LSD, psilocybin, methamphetamine
• schedule one are things like heroin, schedule one are things like heroin, LSD,<00:13:17.680> psilocybin
• , LSD, psilocybin, LSD, psilocybin, methamphetamine. methamphetamine. methamphetamine.

Keywords: 1191, senate, all

Keywords: 1189, house, all

Transcript Highlights:

• Hallucinogens are going to be those that are doing their own mushrooms or psilocybin.

Summary: The committee met to review the Attorney General’s budget and related agency operations, beginning with Legislative Council staff walking members through compliance reports and a blue-sheet base budget document. Staff highlighted current-biennium items such as FTE changes, one-time appropriations, litigation funding, opioid settlement receipts, continuing appropriations, and major special and federal funds. Members asked for clarification on items including the Missing Indigenous People Grant Fund, the Internet Crimes Investigation Fund, and the Medicaid Fraud Control Unit grant funding. Assistant Attorney General Clare Ness then gave an overview of the office’s structure, staffing, and budget pressures. She emphasized the office’s broad statutory duties, the value of its legal services to state and local government, and concerns about attorney pay lagging behind other agencies. Members discussed whether attorney compensation should be benchmarked more consistently across state government and whether some legal work could be consolidated within the AG’s office. Ness also addressed questions about AG opinion turnaround times, boards-and-commissions training, the new-and-vacant FTE pool, operating expense cuts, office leases, and the state’s criminal justice information systems. The crime lab presentation drew significant attention. Director Jennifer Penner described severe space, safety, and infrastructure problems at the current lab, including cramped work areas, glycol leaks, outdated fire and burglar alarms, air-handling limits, and equipment failures that have delayed toxicology work. She said the 2024 study projected a much larger facility would be needed and that the preferred location would be near the current health department site, but in a new building. Members asked about possible evidence risks, backlog status, and whether the proposed building would solve the current problems; Penner said it would and noted backlogs have improved overall, though some delays remain. The committee also heard from the new Medicaid Fraud Control Unit director, who described the unit’s civil and criminal work, federal-state funding split, and examples of fraud such as billing for services not provided or upcoding. The gaming division reported continued growth in charitable gaming and e-tabs, with members expressing concern about large trust-account balances, site competition, and possible misuse of proceeds. Finally, BCI outlined its caseload, cybercrime work, missing Indigenous persons task force, and the surge in CSAM cyber tips; members asked about AI-generated CSAM, and the AG’s office noted that last session’s law increased penalties and expressly allowed AI-generated CSAM to be prosecuted like other CSAM. No formal votes or actions were taken beyond approval of the minutes.

Transcript Highlights:

• They're also adding agents like kratom and psilocybin to these products as well, making them even more

Keywords: 995, all

Summary: The Joint Committee on Cannabis Policy held a hearing on a broad set of cannabis and hemp bills, with the chairs opening by emphasizing unfinished work on equity, public health, safety, and market stability. The committee heard testimony on House Bill 146, which would create more efficient cannabis testing standards by increasing batch sizes, reducing or eliminating some environmental testing, standardizing lab reporting, and requiring annual scientific review and public data reporting. Industry witnesses, including a representative of the Massachusetts Cannabis Coalition, cultivators, and a testing lab owner, said current testing rules are overly burdensome, costly, and inconsistent, and argued the bill would lower compliance costs while preserving consumer safety. A testing lab witness also said some operators switch labs to obtain higher THC results or pass contaminated batches, and urged greater transparency and better sampling protocols. A major portion of the hearing focused on intoxicating hemp and related bills that would bring hemp-derived intoxicating products under a stronger regulatory framework. Legislators and industry witnesses described products sold in gas stations, smoke shops, and convenience stores as often untested, not age-gated, and sometimes mislabeled or far above the federal hemp THC threshold. Testimony from attorneys and cannabis business leaders said states can regulate these products more strictly under the Farm Bill’s non-preemption language, and pointed to New Jersey and other states as possible models. Some witnesses and committee members stressed that any new rules should avoid harming non-intoxicating CBD businesses or lawful hemp farmers, while others argued that the products are effectively cannabis and should be regulated like cannabis for licensing, testing, age limits, and taxation. The committee also heard extensive public-health testimony in support of bills S. 95, S. 96, S. 97 and their House counterparts H. 191, H. 192, and H. 193. Parents, advocates, and public health professionals urged stronger warning labels, THC potency caps, and improved data collection on cannabis-related harms, citing cannabis-induced psychosis, addiction, anxiety, and youth exposure to high-potency products. Several witnesses said Massachusetts has not done enough to track health outcomes or warn consumers, and referenced other jurisdictions such as Connecticut, Vermont, Colorado, Canada, and Quebec as examples of stronger limits or warnings. No votes or formal actions were taken during the hearing; the committee primarily received testimony and questions.

Transcript Highlights:

• You heard at their budget hearing on Monday that they Are making progress on the Medical Psilocybin Act

Keywords: 996, all

Transcript Highlights:

• Hallucinogens are going to be those that are doing their own mushrooms or psilocybin.

Summary: The committee met as the Commerce and Legal Services Division and first approved the minutes, then received a Legislative Council overview of the Attorney General’s current budget status and a blue-sheet summary of the AG’s base budget for the next biennium. Staff highlighted compliance with legislative intent items, including FTE changes, one-time funding updates, litigation pool spending, opioid settlement receipts, and continuing appropriations. Members asked about specific funds such as the Missing Indigenous People Grant Fund and the Internet Crimes Investigation Fund, and staff explained the statutory basis and status of those items. The Attorney General’s office then presented an extensive overview of its divisions and budget pressures. Chief Deputy Attorney General Clare Ness described the office’s 14 divisions, the role of the office in defending the state and recouping funds, and concerns about attorney pay, recruitment, and retention. Members discussed whether attorney salaries should be benchmarked across state government and whether more legal work could be centralized in the AG’s office. The office also described challenges with the new-and-vacant FTE pool, operating expense cuts, leased office space, and the criminal justice information systems used to connect law enforcement, prosecutors, and courts. The Crime Laboratory director gave a detailed update on space and infrastructure problems, saying the current lab is overcrowded and outdated, with safety, workflow, air-handling, glycol leak, alarm, and maintenance issues that can delay casework and risk evidence integrity. She said a 2024 study projected a need for a much larger facility and that the preferred option would be a new building on the current health department site, at an estimated cost of roughly $40 million to $45 million. She also reported that backlogs have improved significantly in DNA, firearms, fingerprint, and drug cases, though toxicology had recently developed a small backlog after an air compressor failure. The Medicaid Fraud Control Unit, gaming division, and BCI also provided updates. MFCU’s new director said the unit is federally funded 75/25, focuses on fraud, abuse, and neglect, and is seeking two attorney hires while continuing to work with federal partners on cases and recertification. Gaming staff reported continued growth in charitable gaming and electronic pull-tab activity, with concerns about site competition, large trust balances, possible ineligible expenditures, and the need for more scrutiny as revenues have grown. BCI outlined its staffing, drug task forces, ICAC work, and the Missing Indigenous Person Task Force, which is using its $250,000 appropriation to help tribal nations develop emergency response plans and purchase alerting tools such as IPAWS. No formal votes were taken beyond approval of the minutes.

Transcript Highlights:

• the fact the state marijuana dispensaries on every corner and has even pushed for decriminalizing psilocybin

Keywords: 995, all

Summary: The hearing covered a wide range of Judiciary Committee bills, with much of the testimony focused on criminal justice, public safety, and civil asset forfeiture reform. Several lawmakers and advocates supported bills to increase penalties or create new offenses related to assaults on sports officials, assaults on transit workers, reckless discharge of firearms, fires and explosives, pill press machines, and drug-induced homicide. Testifiers described rising harassment and violence against youth sports officials and transit workers, as well as the fentanyl overdose crisis and the need for stronger tools to prosecute dealers whose conduct leads to death. Supporters of the sports-official and transit-worker bills emphasized declining referee availability and repeated assaults on commuter rail and MBTA workers. District attorneys also backed bills on reckless firearm discharge and fires/explosives, saying current law does not adequately address dangerous conduct that endangers bystanders. The committee also heard testimony on several proposals related to youth diversion and prison mitigation. Supporters of the youth court justice fund bill said youth courts are peer-led diversion programs with strong compliance and low recidivism, and argued for a stable funding source rather than annual earmarks. A representative from Bridgewater supported a prison mitigation fund for municipalities that host state prisons, saying the costs of public safety and emergency services are not fully covered. On gun policy, testimony split between supporters of a bill to ban in-state manufacture of assault-style rifles for civilian sale and opponents or skeptics of other firearm-related measures, including a bill on collateralizing firearms and a bill to increase penalties for drug trafficking combined with illegal firearm offenses. A major portion of the hearing was devoted to civil asset forfeiture reform. Advocates from the ACLU, CPCS, the Boston Bar Association, the Institute for Justice, and others supported bills to increase the burden of proof, improve transparency and reporting, require counsel, and limit or eliminate the current practice of directing forfeiture proceeds to law enforcement. They argued the current system creates perverse incentives, lacks adequate due process, and is insufficiently transparent. District Attorney Paul Tucker defended current forfeiture practices, saying his office has reporting and oversight, uses the funds for investigations and community programs, and warned that reducing forfeiture revenue would hinder crime fighting. No votes or final committee actions were taken during the hearing; the chairs repeatedly thanked witnesses and indicated the bills would remain under consideration.

Transcript Highlights:

• Again, Senator Steinborn (member_14050) and Senator Hickey (member_14046) on psilocybin mushrooms.

Transcript Highlights:

• You heard at their budget hearing on Monday that they are making progress on the Medical Psilocybin Act

Summary: The Department of Public Safety presented its FY27 budget request, emphasizing three priorities: improving community engagement through a redesigned website and outreach, expanding statewide data and intelligence integration through intelligence-led policing, and improving emergency response and officer safety through fleet replacement, a driving track, and a requested helicopter. DPS said much of its increase is driven by rising health care premiums, and it is also seeking special appropriations for fleet replacement, the website rebuild, and an Honor Guard program created after the 2022 helicopter crash that killed four public servants. Members asked about vacancies, fleet costs, cybersecurity compliance, the real-time crime center, EV fleet participation, and the Metro DPS facility. DPS said its vacancy rate is about 9%, its fleet replacement needs are driven by mileage and condition, it is compliant with federal CJIS standards even though DoIT has raised concerns, the real-time crime center would be built as a regional model to complement Albuquerque’s center, and the Metro facility is moving toward a January groundbreaking. Committee members also discussed several DPS-related capital and IT requests, including the intelligence-led policing data lake, recurring maintenance for critical systems, and a $5.6 million reauthorization for state crime lab DNA backlog work and a $900,000 reauthorization for fingerprinting equipment. DPS explained that the website request is high because the current site must be rebuilt from scratch to support missing-person alerts, memorial updates, ADA compliance, and better communication with law enforcement and the public. Members also raised concerns about speed enforcement, construction-zone cameras, and whether EVs are practical for patrol use; DPS said it is not pursuing speed cameras and is only partially participating in the state EV initiative because patrol needs make full electrification difficult. The committee then received an LFC quarterly update on non-recurring appropriations from the 2025 General Appropriation Act. LFC reported that of the $1.4 billion appropriated in Section 5, $164 million had been expended and $333 million encumbered, leaving $897.4 million unspent, which is a slower pace than the prior year. Staff highlighted a number of reauthorization requests and slow-moving projects across agencies, including AOC cybersecurity funding, DFA housing and public safety grants, DoIT cybersecurity and higher education funds, EDD economic development and energy programs, OSI mitigation and malpractice funds, EMNRD energy and geothermal grants, Health Care Authority behavioral health-related appropriations, DPS crime lab and fingerprinting funds, PED career technical education and special education initiatives, and higher education loan repayment and technology funds. Members questioned why some large appropriations had little or no spending, discussed the need to monitor reauthorizations more closely, and asked for follow-up on several specific line items and project balances.

Transcript Highlights:

• And right now, um, psilocybin is a Schedule 1 drug. So we have some potential issues there.
• and<01:25:02.320> right<01:25:02.560> now<01:25:03.280> um<01:25:03.520> psilocybin
• <01:25:04.239> is<01:25:04.400> a >> and right now um psilocybin is a >>
• ; and right now um psilocybin is a schedule<01:25:04.800> one<01:25:05.040> drug.

Keywords: 1189, house, all

Transcript Highlights:

• Next month, in July, we'll focus on learning more about alternative therapies, such as psilocybin and

Keywords: 959, house, all

Transcript Highlights:

• Next month, in July, we'll focus on learning more about alternative therapies, such as psilocybin and

Summary: The task force meeting opened with new leadership announcements, including Senator Nick Schroer thanking outgoing chair Representative John Black and naming Representative Del Taylor as vice chair. After some initial technical difficulties with audio and Zoom, members reviewed the task force’s statutory charge under Missouri law: to hold hearings on substance use, explore solutions, draft or modify legislation, and produce recommendations for prevention and treatment. The chair said the goal for this year is to develop concrete legislative ideas for the next session, with hearings focused first on field experts and later on alternative therapies and the Department of Mental Health. Dr. Rachel Winograd gave the first major presentation, describing Missouri’s overdose crisis as increasingly complex and driven primarily by fentanyl, now compounded by xylazine and metatomidine. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, and attributed the decline to a smaller fentanyl supply, wider naloxone availability, and fewer young people entering use. Her main recommendations were to focus on reducing harm rather than trying to eliminate drug use, expand evidence-based medications for opioid use disorder—especially methadone and buprenorphine—improve access to naloxone, and loosen methadone regulations, including take-home doses, the federal 72-hour rule, and broader methadone units. She also emphasized that peer support, housing, transportation, and other practical supports matter, and noted that naloxone can still reverse fentanyl overdoses even when tranquilizers are present. Dr. Heidi Miller, the state medical director, followed with two recommendations: integrate substance use disorder care into whole-person health care and follow the science when considering substance-related legislation. She argued that primary care, maternal health, workforce training, EMS, public health, and methadone access should all be part of a coordinated model, and said reimbursement should support teams rather than isolated providers. She also urged stronger enforcement of parity between behavioral health/SUD and physical health coverage, and highlighted tobacco and alcohol as major, under-addressed causes of death in Missouri. Dr. Doug Burgess then reinforced the need for a coordinated continuum of care, comparing substance use treatment to the seamless system used for heart attacks, and said patients should have standardized assessment, discharge planning from day one, transition coordinators, peer recovery coaches, and better information-sharing between levels of care. Members asked questions about relapse, treatment court, EMS referral barriers, reimbursement, and whether buprenorphine can be started in the field; no votes were taken, and the meeting ended with plans to continue hearing testimony and use it to shape future policy recommendations.

Transcript Highlights:

• And this bill is also going to launch the first step of the very popular medical and medicinal psilocybin

Keywords: 919, house, all

Summary: The House first took up Senate File 334, a bill to modernize county human services technology used to administer programs such as Medicaid and SNAP. The author and several members described the current systems as outdated “green screen” platforms that are slow, duplicative, and difficult for workers and applicants, and argued modernization would improve service, retention, and fraud prevention. The bill would create a technology modernization fund with about $90 million over time, capped at $50 million, route funds through Minute, establish an interagency group with county representation, create a legislative working group, and provide $15 million for Office of Inspector General technology. Members from several counties spoke in strong support, citing local system failures, cyberattacks, and the need for better tools; one member noted the bill was about 20 years overdue. The bill passed third reading by a vote of 134-0, and a title was agreed to. The House then considered Senate File 4401, the cannabis bill. The author described it as a maintenance and cleanup package developed with more than 80 stakeholders over months of meetings, including business owners, labor, tribal representatives, and medical cannabis interests. The bill was presented as making noncontroversial adjustments to support small businesses, clarify statutes, improve privacy protections, adjust event and transporter rules, address good-faith errors, strengthen enforcement against unlicensed operators, and support local governments and municipal cannabis dispensaries. It also included a first step toward a medical psilocybin program and changes intended to make the medical cannabis market more sustainable, including easing the grow-and-sale ratio issue. The transcript cuts off before final action on this bill, but members speaking in support emphasized collaboration and the need for practical regulatory fixes.